0001839882-23-006927.txt : 20230316 0001839882-23-006927.hdr.sgml : 20230316 20230316194205 ACCESSION NUMBER: 0001839882-23-006927 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230315 FILED AS OF DATE: 20230316 DATE AS OF CHANGE: 20230316 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Stillwell Richard Newcomb CENTRAL INDEX KEY: 0001966861 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36019 FILM NUMBER: 23740341 MAIL ADDRESS: STREET 1: C/O TONIX PHARMACEUTICALS HOLDING CORP. STREET 2: 26 MAIN STREET, SUITE 101 CITY: CHATHAM STATE: NJ ZIP: 07928 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Tonix Pharmaceuticals Holding Corp. CENTRAL INDEX KEY: 0001430306 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 261434750 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 26 MAIN STREET, SUITE 101 CITY: CHATHAM STATE: NJ ZIP: 07928 BUSINESS PHONE: 212-980-9155 MAIL ADDRESS: STREET 1: 26 MAIN STREET, SUITE 101 CITY: CHATHAM STATE: NJ ZIP: 07928 FORMER COMPANY: FORMER CONFORMED NAME: TAMANDARE EXPLORATIONS INC. DATE OF NAME CHANGE: 20080320 3 1 stillwell-form3_031523.xml STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP X0206 3 2023-03-15 0 0001430306 Tonix Pharmaceuticals Holding Corp. TNXP 0001966861 Stillwell Richard Newcomb C/O TONIX PHARMACEUTICALS HOLDING CORP 26 MAIN ST., SUITE 101 CHATHAM NJ 07928 1 0 0 0 Stock Option 0.562 2023-03-15 Common Stock 83000 D The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan. This option vests on the Issuer's 2023 Annual Meeting of Stockholders. /s/ Jessica Morris as attorney-in-fact 2023-03-16